eastman kodak said plans sell its pct holding icn pharmaceuticals and part its nine pct holdings viratek said purpose investments had been lay groundwork for creation its nucleic acid research institute since has been achieved longer any reason maintain equity positions kodak said kodak holds 470 000 sahres icn currently trading about and 700 000 viratek trading reuter 